U S Physical Therapy INC /NV 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NYSE
U.S. Physical Therapy, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting an increase in net revenue driven by physical therapy and industrial injury prevention services.
NYSE
U.S. Physical Therapy reports Q1 2026 net revenue of $198.3 million, up 7.9% year-over-year, despite a decline in net income attributable to shareholders.
NYSE
U.S. Physical Therapy, Inc. announced significant revenue and profit increases for the third quarter and first nine months of 2025, driven by strategic acquisitions and higher patient volumes.
NYSE
U.S. Physical Therapy, Inc. announced significant revenue and earnings growth for the second quarter and first half of 2025, driven by strategic acquisitions and increased patient visits.
NYSE
U.S. Physical Therapy, Inc. announces a robust first quarter for 2025, marked by revenue growth from strategic acquisitions and improved patient service rates.
NYSE
U.S. Physical Therapy, Inc. announced its third-quarter results, showing a decrease in net income attributable to USPH shareholders, impacted by clinic closures, while also reporting growth in revenue and adjusted EBITDA.
NYSE
10-Q: U.S. Physical Therapy Reports Mixed Second Quarter Results Amidst Revenue Growth and Margin Pressure
U.S. Physical Therapy saw a revenue increase in the second quarter of 2024, but faced challenges with gross profit margins and increased operating costs.
NYSE
10-Q: U.S. Physical Therapy Reports Mixed Q1 Results Amidst Medicare Rate Changes and Weather Impact
U.S. Physical Therapy's first quarter saw a revenue increase but a decrease in profitability due to Medicare rate reductions and adverse weather conditions.